Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates (Q37077660)

18 August 2017

1 reference

title

Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates (English)

1 reference

18 August 2017

Ron Dagan

1 reference

18 August 2017

Jan T Poolman

1 reference

18 August 2017

Fred Zepp

series ordinal

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

97-115

1 reference

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

The UK Hib vaccine experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Conjugate vaccines and the carriage of Haemophilus influenzae type b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Assessing efficacy of Haemophilus influenzae type b combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Clinical relevance of lower Hib response in DTPa-based combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate v

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Evolution of conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Haemophilus influenzae b-vaccination: the urgency for timely vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vac

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Effect of breast-feeding on antibody response to conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Imperfect memory and the development of Haemophilus influenzae type B disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Hib vaccination in infants born prematurely

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vacci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.97

21 January 2018

Identifiers

DOI

10.1586/14760584.7.1.97

1 reference

release_uj7r36ljdbh27mi5ysmjd2hw7i

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uj7r36ljdbh27mi5ysmjd2hw7i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference